These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26000477)

  • 41. The RAS/Raf1/MEK/ERK signaling pathway facilitates VSV-mediated oncolysis: implication for the defective interferon response in cancer cells.
    Noser JA; Mael AA; Sakuma R; Ohmine S; Marcato P; Lee PW; Ikeda Y
    Mol Ther; 2007 Aug; 15(8):1531-6. PubMed ID: 17505473
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Essential, non-redundant roles of B-Raf and Raf-1 in Ras-driven skin tumorigenesis.
    Kern F; Doma E; Rupp C; Niault T; Baccarini M
    Oncogene; 2013 May; 32(19):2483-92. PubMed ID: 22733131
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radicicol suppresses transformation and restores tropomyosin-2 expression in both ras- and MEK-transformed cells without inhibiting the Raf/MEK/ERK signaling cascade.
    Kim PN; Jonasch E; Mosterman BC; Mier JW; Janssen RA
    Cell Growth Differ; 2001 Nov; 12(11):543-50. PubMed ID: 11714635
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activation and role of MAP kinase-dependent pathways in retinal pigment epithelial cells: ERK and RPE cell proliferation.
    Hecquet C; Lefevre G; Valtink M; Engelmann K; Mascarelli F
    Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):3091-8. PubMed ID: 12202534
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The RAF family: an expanding network of post-translational controls and protein-protein interactions.
    Yuryev A; Wennogle LP
    Cell Res; 1998 Jun; 8(2):81-98. PubMed ID: 9669024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effects of electromagnetic radiation on RAF/MEK/ERK signaling pathway in rats hippocampus].
    Zuo HY; Wang DW; Peng RY; Wang SM; Gao YB; Xu XP; Ma JJ
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2009 May; 25(2):186-9. PubMed ID: 21189547
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization.
    Garnett MJ; Rana S; Paterson H; Barford D; Marais R
    Mol Cell; 2005 Dec; 20(6):963-9. PubMed ID: 16364920
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CrkL plays a role in SDF-1-induced activation of the Raf-1/MEK/Erk pathway through Ras and Rac to mediate chemotactic signaling in hematopoietic cells.
    Arai A; Aoki M; Weihua Y; Jin A; Miura O
    Cell Signal; 2006 Dec; 18(12):2162-71. PubMed ID: 16781119
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.
    Roberts PJ; Der CJ
    Oncogene; 2007 May; 26(22):3291-310. PubMed ID: 17496923
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Apicobasal polarity and Ras/Raf/MEK/ERK signalling in cancer.
    Peng J; Gassama-Diagne A
    Gut; 2017 Jun; 66(6):986-987. PubMed ID: 27974551
    [No Abstract]   [Full Text] [Related]  

  • 51. Raf-1 addiction in Ras-induced skin carcinogenesis.
    Ehrenreiter K; Kern F; Velamoor V; Meissl K; Galabova-Kovacs G; Sibilia M; Baccarini M
    Cancer Cell; 2009 Aug; 16(2):149-60. PubMed ID: 19647225
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Strong negative feedback from Erk to Raf confers robustness to MAPK signalling.
    Fritsche-Guenther R; Witzel F; Sieber A; Herr R; Schmidt N; Braun S; Brummer T; Sers C; Blüthgen N
    Mol Syst Biol; 2011 May; 7():489. PubMed ID: 21613978
    [TBL] [Abstract][Full Text] [Related]  

  • 53. RAF-isotype switching: from B to C through PDE.
    Lau E; Ronai Z
    Nat Struct Mol Biol; 2011 May; 18(5):517-8. PubMed ID: 21540889
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Raf-1 protein kinase, signal transduction, and targeted intervention of radiation response.
    Kasid U
    Exp Biol Med (Maywood); 2001 Jul; 226(7):624-5. PubMed ID: 11444096
    [No Abstract]   [Full Text] [Related]  

  • 55. A zinc transporter protects from ischemia-reperfusion injury.
    Luft FC
    J Mol Med (Berl); 2012 Feb; 90(2):101-3. PubMed ID: 22274561
    [No Abstract]   [Full Text] [Related]  

  • 56. Targeting of non-oncogene addiction.
    Igea A; Gupta J; Nebreda AR
    Aging (Albany NY); 2015 Aug; 7(8):525-6. PubMed ID: 26298432
    [No Abstract]   [Full Text] [Related]  

  • 57. Editorial: Identifying the isoform-specific roles of RAS paralogs in health and disease.
    Nakhaei-Rad S; Fejtova A
    Front Cell Dev Biol; 2023; 11():1199356. PubMed ID: 37123419
    [No Abstract]   [Full Text] [Related]  

  • 58. Balancing effector outputs.
    Stock J
    Curr Biol; 1991 Jun; 1(3):154-6. PubMed ID: 15336152
    [No Abstract]   [Full Text] [Related]  

  • 59. Ras-GTP dimers activate the Mitogen-Activated Protein Kinase (MAPK) pathway.
    Nan X; Tamgüney TM; Collisson EA; Lin LJ; Pitt C; Galeas J; Lewis S; Gray JW; McCormick F; Chu S
    Proc Natl Acad Sci U S A; 2015 Jun; 112(26):7996-8001. PubMed ID: 26080442
    [TBL] [Abstract][Full Text] [Related]  

  • 60. RasGRP1 opposes proliferative EGFR-SOS1-Ras signals and restricts intestinal epithelial cell growth.
    Depeille P; Henricks LM; van de Ven RA; Lemmens E; Wang CY; Matli M; Werb Z; Haigis KM; Donner D; Warren R; Roose JP
    Nat Cell Biol; 2015 Jun; 17(6):804-15. PubMed ID: 26005835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.